Aspirin reduces the risk for colorectal cancer in high-risk groups, such as Lynch syndrome, but shows no benefit in the ...

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., April 09, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; ...

Sensei Biotherapeutics, Inc. (Nasdaq: SNSE) today reported financial results for the full year ended December 31, 2025, ...

Researchers in the Perelman School of Medicine at the University of Pennsylvania have identified a cell surface receptor ...

Cancer stem cells (CSCs), a critical subpopulation within tumors, drive cancer initiation, progression, metastasis, relapse, ...

Relay Therapeutics announced that initial clinical and preclinical data for its PI3K⍺-targeting candidate zovegalisib in vascular anomalies will be presented at the International Society for the Study ...

EMA’s panel backs a targeted therapy, which reduces lymphadenopathy and restores B-cell populations in patients with activated phosphoinositide 3-kinase delta syndrome.

The data shows that inhibiting TIE2 with rebastinib could prevent new abnormalities from forming in the brain with fewer side effects.

Can we prevent brain hemorrhages without surgery? New research identifies TIE2 as a key driver of cerebral cavernous malformations (CCMs). Discover how the drug rebastinib could provide a safer, ...

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive memory loss, cognitive decline, and behavioral changes. The deficits linked to AD are known to result from the ...

Breast cancer (BCA) is one of the most common cancers worldwide, with a high rate of mortality and morbidity in women. This ...